advertisement

Oculus

11.4 Prostaglandins (141)

Showing records 1 to 25

Display all abstracts in classification 11.4 Prostaglandins

Search within classification 11.4 Prostaglandins
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Coleman RA
British Journal of Pharmacology 2019; 176: 687-698
80765 Ocular Surface Evaluation After the Substitution of Benzalkonium Chloride Preserved Prostaglandin Eye Drops by a Preservative-free Prostaglandin Analogue
Lopes NLV
Medical hypothesis, discovery and innovation in ophthalmology 2019; 8: 52-56
80622 An in vivo confocal, prospective, masked, 36 months study on glaucoma patients medically treated with preservative-free or preserved monotherapy
Rossi GCM
Scientific reports 2019; 9: 4282
80850 Randomized crossover trial comparing effectiveness and tolerability of generic and brand-name travoprost
Ta Kim D
Canadian Journal of Ophthalmology 2019; 54: 223-228
80766 A case of latanoprost-induced diffuse facial skin hyperpigmentation
Kim HY
Journal of cosmetic dermatology 2019; 18: 1717-1720
81242 Latanoprost treatment differentially affects intraocular pressure readings obtained with three different tonometers
Sánchez-Barahona C
Acta Ophthalmologica 2019; 97: e1112-e1115
81351 Meibomian gland dropout rate as a method to assess meibomian gland morphologic changes during use of preservative-containing or preservative-free topical prostaglandin analogues
Lee SY
PLoS ONE 2019; 14: e0218886
81437 Efficacy of travoprost for the treatment of patients with glaucoma
Zhang XL
Medicine 2019; 98: e16526
81435 The effects of prostaglandins and endocannabinoids on iris arterial vascularization in Wistar rats - Experimental analysis
Coman IC
Romanian journal of ophthalmology 2019; 63: 135-141
81446 Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
Tang W
Medicine 2019; 98: e16597
80714 Shortening of Interpupillary Distance after Instillation of Topical Prostaglandin Analogue Eye Drops
Sano I
American Journal of Ophthalmology 2019; 206: 11-16
80652 Topical medical therapy and ocular perfusion pressure in open angle glaucoma: a systematic review and meta-analysis
Rennie G
Current Medical Research and Opinion 2019; 35: 1421-1431
80665 Effects of Anti-Glaucoma Prostaglandin Ophthalmic Solutions on Cultured Human Corneal Epithelial Cells
Tong L
Current Eye Research 2019; 44: 856-862
81447 Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation
Yadav M
Materials science & engineering. C, Materials for biological applications 2019; 103: 109730
80450 Direct and crossover effects of brinzolamide, betaxolol, and latanoprost on choroidal thickness
Okutucu M
Cutaneous and Ocular Toxicology 2019; 38: 196-200
80582 The effect of topical latanoprost on corneal clarity; 1-year prospective study
Sen E
Cutaneous and Ocular Toxicology 2019; 38: 253-257
81367 Omidenepag isopropyl for the treatment of glaucoma and ocular hypertension
Ferro Desideri L
Drugs of Today 2019; 55: 377-384
80739 Effects of aqueous suppressants and prostaglandin analogues on early wound healing after glaucoma implant surgery
Jung KI
Scientific reports 2019; 9: 5251
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Coleman RA
British Journal of Pharmacology 2019; 176: 687-698
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
Liu Y
Frontiers in pharmacology 2019; 10: 679
80713 Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma
Hayashi K
American Journal of Ophthalmology 2019; 205: 91-98
80738 Decreased orbital fat and enophthalmos due to bimatoprost: Quantitative analysis using magnetic resonance imaging
Higashiyama T
PLoS ONE 2019; 14: e0214065
81381 Effects of the Glaucoma Drugs Latanoprost and Brimonidine on Corneal Temperature
Konieczka K
Translational vision science & technology 2019; 8: 47
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Aihara M
Journal of Glaucoma 2019; 28: 375-385
81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Xu J
Journal of Controlled Release 2019; 305: 18-28

Issue 20-3

Select Issue


advertisement

Oculus